PropertyValue
?:abstract
  • In late 2019, a novel coronavirus initially related to a cluster of severe pneumonia cases in China was identified COVID-19 cases have rapidly spread to multiple countries worldwide We present a typical laboratory confirmed case of COVID-19 pneumonia, that was hospitalized due to hypoxemia but did not require mechanical ventilation Although initially the patient was evaluated with a favorable outcome, in the third week of the disease, the symptomatology deteriorated due to a massive hypertensive pneumothorax with no known previous risk factor Since the first cases of COVID-19 have been described, pneumothorax was characterized as a potential, though uncommon, complication It has been reported that diffuse alveolar injury caused by SARS-CoV-2 can cause alveolar rupture, produce air leakage and interstitial emphysema Although uncommon, pneumothorax should be listed as a differential diagnosis for COVID-19 patients with sudden respiratory decompensation As a life-threatening event, it requires prompt recognition and expeditious treatment
is ?:annotates of
?:creator
?:journal
  • Revista_do_Instituto_de_Medicina_Tropical_de_Sao_Paulo
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Pneumothorax as a late complication of COVID-19
?:type
?:who_covidence_id
  • #963874
?:year
  • 2020

Metadata

Anon_0  
expand all